Integration of motivational interviewing and cognitive behavioral therapy to improve HIV medication adherence and reduce substance use among HIV-positive men and women: Results of a pilot project

AIDS Patient Care and STDs

Volumn 19, Issue 1, 2005, Pages 31-39

  Parsons, Jeffrey T ^a,b   Rosof, Elana ^b   Punzalan, Joseph C ^a,b   Di Maria, Lauren ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ILLICIT DRUG;

ADULT; ARTICLE; BEHAVIOR THERAPY; COGNITION; COGNITIVE THERAPY; COPING BEHAVIOR; DOCTOR PATIENT RELATION; DRUG USE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MALE; MOTIVATION; PATIENT COMPLIANCE; PILOT STUDY; RECURRENCE RISK; RISK ASSESSMENT; RISK REDUCTION; SUBSTANCE ABUSE;

ADULT; AGE FACTORS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATTITUDE TO HEALTH; COGNITIVE THERAPY; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INTERVENTION STUDIES; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION; PILOT PROJECTS; RISK ASSESSMENT; SEX FACTORS; SUBSTANCE-RELATED DISORDERS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 12844262156     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2005.19.31     Document Type: Article

References (37)

1. Wagner GJ. Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries. AIDS Patient Care STDs 2002;16:599-608.
2. Arnsten JH, Demas PA, Grant RW, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med 2002;17:377-381.
3. Carrieri MP, Chesney MA, Spire B, et al. Failure to maintain adherence to HAART in a cohort of French HIV-positive injection drug users. Int J Behav Med 2003;10:1-14.
4. Dilorio C, Resnicow K, McDonnell M, et al. Using motivational interviewing to promote adherence to antiretroviral medications: A pilot study. J Assoc Nurses AIDS Care 2003;14:52-62.
5. Gebo KA, Keruly J, Moore RD. Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapy. J Gen Inter Med 2003;18:104-112.
6. Miguez-Burbano MJ, Pineda-Medina L, Lecusay R. Continued high risk behaviors in HIV infected drug abusers. J Addict Dis 2002;21:67-75.
7. Reback CJ, Larkins S, Shoptaw S. Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care 2003;15:775-786.
8. Bangsberg DR, Hecht FM, Clague H, et al. Provider assessment of adherence to HIV antiretroviral therapy. J Acquir Immune Defic Syndrome 2001;26:435-443.
9. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitory therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
10. Freeman RC, Rodriguez GM, French JF. Compliance with AZT treatment regiment of HIV-seropositive injection drug users. AIDS Educ Prev 1996;8:58-71.
11. Halkitis P, Parsons J, Wolitski R, et al. Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men. AIDS Care 2003;15:89-102.
12. Hirschhorn L, Quinones J, Goldin S, Metras L. Highly active anti-retroviral therapy (HAART) in the "real world": Experiences in an inner-city community health center (CHC). 12th World AIDS Conference, Geneva, Switzerland, June 1998.
13. Misener TR, Sowell RL. HIV-infected women's decisions to take antiretrovirals. Western J Nursing Res 1998;20:431-448.
14. Nannis ED, Temoshok LR, Smith M, et al. Perceptions of AZT: Implications for adherence to medical regimens. J Appl Biobehav Res 1993;1:39-54.
15. Turner BJ, Fleishman JA, Wenger N, et al. Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. J Gen Intern Med 2001;16:625-633.
16. Batson HW, Brown LS, Zaballero AR. Conflicting measurements of depression in a substance abuse population. J Subst Abuse 1993;5:93-100.
17. Bouhnik A, Chesney M, Carrieri P, et al. Nonadherence among HIV-infected injecting drug users: the impact of social instability. J Acquir Immune Defic Syndrome 2002;31:149-154.
18. Witteveen E, van Ameijden E. Drug users and HIV combination therapy (HAART): Factors which impede or facilitate adherence. Substance Use Misuse 2002;37:1905-1925.
19. Amrhein PC, Miller WR, Yahne CE, et al. Client commitment language during motivational interviewing predicts drug use outcomes. J Consult Clin Psych 2003;71:862-879.
20. Baer JS, Kivlahan DK, Donovan DM. Integrating skills training and motivational therapies: Implacations for the treatment of substance dependence. J Subst Abuse Treat 1999;17:15-23.
21. Kalichman SC, Cherry C, Browne-Sperling F. Effectiveness of a video-based motivational skills-building HIV risk-reduction intervention for inner-city African American men. J Consult Clin Psych 1999;67:959-966.
22. Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change, 2nd ed. New York, NY: Guilford Press; 2002.
23. Marlatt GA, Gordon JR. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York, NY: Guilford Press, 1985.
24. Gribble JN, Miller HG, Rogers SM, Turner CF. Interview mode and measurement of sexual behaviors: Methodological issues. J Sex Res 1999;36:16-25.
25. Turner CF, Ku L, Rogers SM, Linberg LD, Pleck JH, Sonenstein FL. Adolescent sexual behavior, drug use, and violence: Increased reporting with computer survey technology. Science 1998;280:867-874.
26. Des Jarlais DC. Validity of self-reported data, scientific methods and drug policy. Drug Alcohol Depend 1998;51:265-266.
27. Tourangeau R, Smith TW. Asking sensitive questions: The impact of data collection mode, question format, and question context. Public Opin Q 1996;60:275-305.
28. Kalichman SC. Preventing AIDS: A Sourcebook for Behavioral Interventions. London: LEA, 1998.
29. Sobell LC, Sobell MB. Timeline follow-back: A technique for assessing self-reported alcohol consumption. In Litton R, Allen, JP, eds. Measuring Alcohol Consumption: Psychosocial and Biochemical Methods. Totowa, NJ: Humana Press, 1992:41-69.
30. Skinner HA. Statistical approaches to the classification of alcohol and drug addiction. Br J Addict 1982;77:259-274.
31. El-Bassel N, Schilling R, Schinke S. Assessing the utility of the Drug Abuse Screening Test in the workplace. Res Social Work Pract 1997;7:99-114.
32. Maisto SA, Carey MP, Carey KB, Gordon CM, Gleason JR. Use of the AUDIT and the DAST-10 to identify alcohol and drug use disorders among adults with a severe and persistent mental illness. Psychol Assess 2000;12:186-192.
33. DiClemente CC, Carbonari JP, Montgomery RP. The alcohol abstinence self-efficacy scale. J Stud Alcohol 1994;55:141-148.
34. Halkitis PN, Kutnick AH, Rosof E, Slater S, Parsons JT. Adherence to HIV medications in a cohort of men who have sex with men: Impact of 9/11. J Urban Health 2003;80:161-166.
35. Horvath AO, Greenberg LS. Development and validation of the Working Alliance Inventory. J Counse Psych 1989;36:223-233.
36. Nemes S, Wish E, Wraight B, et al. Correlates of treatment follow-up difficulty. Substance Use Misuse 2002;37:19-46.
37. Chesney MA, Chambers DB, Taylor JM., et al. Social support, distress, and well-being in older men living with HIV infection. J Acquir Immune Defic Syndrome 2003;33:185-194.